Research
Study finds tau fragment may help identify advanced CTE
Blood levels of eMTBR-tau243 were higher in people with advanced CTE, but the biomarker did not reliably identify early-stage disease.
Researchers at Washington University in St. Louis reported preliminary findings that a tau fragment called eMTBR-tau243 may help identify chronic traumatic encephalopathy (CTE) in people who are still alive. They tested stored blood from 11 people who had been classified as having CTE. Compared with healthy people, those with advanced CTE had higher levels of the biomarker, study coauthor Chihiro Sato said. The biomarker could not reliably identify early-stage CTE.
A CTE diagnosis can currently be confirmed only by examining the brain after death, and symptoms such as memory loss and mood swings can also occur in other diseases, the reports said. Neuropathologist Rudolph Castellani, who was not involved in the research, called the result very preliminary. The researchers and Castellani said much larger studies are needed to assess whether the finding has diagnostic value. The findings were published in JAMA and presented at a scientific meeting in Japan.


